CDTX vs COST · rev $1.3M vs P/E 55, rev $275.24B
Cidara Therapeutics Inc (CDTX) versus Costco Wholesale Corp (COST) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Costco Wholesale Corp (COST) is a discount stores company listed on US. It is led by Ron Vachris.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported COST revenue for 2025-08-31 was $275.24B. Net income was $8.10B. Revenue was up 8.2% from 2024-09-01 to 2025-08-31. COST currently screens at market cap $430.32B and trailing P/E 54.9.
CDTX currently screens at market cap $6.96B. COST currently screens at market cap $430.32B and trailing P/E 54.9.
Not investment advice. Open the CDTX and COST stock pages for the full models.
Not investment advice.